Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-115 clinical pharmacology study in diabetic macular edema
jRCT2080222406Phase 2
- Sponsor
- Kowa Company, Ltd.
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ripasudil in type 2 diabetes mellitus (T2DM), diabetic retinopathy (DR) and diabetic macular edema (DME), sponsored by Kowa Company, Ltd.
02
Drugs
ripasudil
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic retinopathy (DR)diabetic macular edema (DME)
Beyond the preview
Go deeper on jRCT2080222406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222406.